ARCHIVES

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

This article is from The Cancer Letter archive.

Vol. 01 No. 39 | November 1, 1974

Download PDF Visit The Full Archive

Related Articles

Private Institute Commits $1 Million Pick Up some NIH Grants Left Unfunded

April 19, 1985

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

February 14, 2014

First Report On Carcinogens Now Avaiable

October 3, 1980

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994